Bill Commons

NJ A 5722

in committee

Requires hotels and harm reduction service providers to cooperate in providing opioid antidotes and harm reduction supplies at hotels.

New Jersey · 222

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did NJ A 5722 pass?

Not yet. NJ A 5722 is in committee and has not come to a final vote. Latest recorded action (2026-10-29): Introduced, Referred to Assembly Tourism, Gaming and the Arts Committee

What is NJ A 5722 about?

NJ A 5722 is a bill in the 222 titled “Requires hotels and harm reduction service providers to cooperate in providing opioid antidotes and harm reduction supplies at hotels.”.

Who sponsors NJ A 5722?

Dunn, Aura K. is the primary sponsor of NJ A 5722.

Introduced
—
Latest action
2026-10-29 — Introduced, Referred to Assembly Tourism, Gaming and the Arts Committee
Bill type
bill
Last updated
—

Sponsors

  • Dunn, Aura K.primary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-10-29

    Introduced, Referred to Assembly Tourism, Gaming and the Arts Committee

    introduction,referral-committee

Versions

Not provided by source.

Documents

Not provided by source.

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_api_sync, retrieved 2026-10-30T04:33:04.484170Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=A 5722. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.